The Clinical Research Secretariat (CRS) Department at TMC has been a pillar of support for groundbreaking medical research since its inception in 1997. It plays a pivotal role in advancing clinical research and cancer treatment through high-impact investigator-initiated trials, sponsored and collaborative studies. What started as a small yet visionary research initiative has now grown into a robust and dynamic department with the support of Department of Atomic Energy Clinical Trials Centre (DAE-CTC) since 2003, facilitating cutting-edge research, evidence-based medicine, and capacity building.,
serving as the backbone of all research activities within the hospital.
CRS is the cornerstone of innovation in research, leading to groundbreaking low cost treatments, enhanced patient care, and improved disease management & development Evidence Based guidelines. CRS department supports researchers from study conception to completion, assisting with protocol development, funding applications, ethical approvals, Biostatistical cell and participant recruitment. By providing a seamless research infrastructure, we enable investigators to focus on discovery while we handle the complexities of research administration. Whether it’s pioneering drug trials, cutting-edge medical device studies, or epidemiological research,
our CRS is dedicated to advancing medical knowledge and translating scientific findings into real-world healthcare solutions